Nitazoxanide, Ivermectin, and Artemether effects against cryptosporidiosis in diabetic mice: parasitological, histopathological, and chemical studies

被引:4
作者
El-Ashkar A.M. [1 ]
Mahmoud S. [2 ]
Sabry H. [2 ]
Guirguis N. [2 ]
El Komi W. [2 ]
Ali E. [2 ]
Abu Shousha T. [3 ]
Abdelmksoud H.F. [2 ]
机构
[1] Department of Medical Parasitology, Faculty of Medicine, Ain Shams University, Cairo
[2] Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza
[3] Department of Pathology, Theodor Bilharz Research Institute, Giza
关键词
Artemether; Cryptosporidium; Diabetes mellitus; Ivermectin; Nitazoxanide;
D O I
10.1007/s12639-022-01527-w
中图分类号
学科分类号
摘要
Human cryptosporidiosis is one of the most significant causes of water borne epidemics of diarrhea worldwide. It is extremely important in immunocompromised hosts and malnourished children as it could cause severe life-threatening diarrhea. Despite the global burden of the disease, there are only few available therapies against cryptosporidiosis. Diabetes mellitus is a common metabolic disorder that impair both the innate and adaptive immune responses of the patient. This study aimed to test the effect of Nitazoxanide, Ivermectin, and Artemether against cryptosporidiosis in diabetic mice. Sixty white albino mice were categorized into 6 groups; 10 mice each: GI: normal non-infected non-treated (healthy- control), GII-GVI (diabetic groups), GII: non-infected non treated (diabetic control), GIII: infected non treated (infected control), GIV: infected and treated with Nitazoxanide (NTZ), GV: infected and treated with Ivermectin (IVC), GVI: infected and treated with Artemether (ART). Parasitological, histopathological, and chemical examinations were done to evaluate the effect of NTZ, IVC, and ART against cryptosporidiosis in diabetic mice. Parasitological examination revealed maximum reduction of oocyst shedding in GVI, while histopathological examination showed the least pathologic changes in GV with mild vascular wall fibrosis and moderate lymphocytic infiltration of islets of Langerhans. Measurement of blood glucose level showed the best results with GIV. Nitazoxanide is effective against cryptosporidiosis in diabetic patients with minimal hyperglycemia, Artemether is especially effective in reducing the oocyst shedding in stool, whereas Ivermectin is associated with the least pathological changes in pancreatic islets of Langerhans. Graphical abstract: [Figure not available: see fulltext.] © 2022, Indian Society for Parasitology.
引用
收藏
页码:1070 / 1079
页数:9
相关论文
共 60 条
[1]  
Abaza B., Hamza R., Farag T., Et al., Assessing the efficacy of nitazoxanide in treatment of cryptosporidiosis using pcr examination, J Egypt Soc Parasitol, 46, pp. 683-692, (2016)
[2]  
Abaza S., Makhlouf L., El-Shewy K., El-Moamly A., Intestinal opportunistic parasites among different groups of immunocompromised hosts, J Egypt Soc Parasitol, 25, pp. 713-727, (1995)
[3]  
Abdelmaksoud H., Aboushousha T., El-Ashkar A., Efficacy of coconut oil as therapeutic agent with potential anticancer activity in immunosuppressed mice with cryptosporidiosis: Parasitological, histopathological and immunohistochemical studies, Parasitol United J, 15, pp. 45-52, (2022)
[4]  
Abdelmaksoud H., Aboushousha T., El-Ashkar A., Deep glance on the antiparasitic anticancer activities of wheat germ oil in chronically infected immunosuppressed mice with cryptosporidiosis, J Parasit Dis, 46, pp. 1-10, (2022)
[5]  
Abdelmaksoud H.F., El-Ashkar A.M., Elgohary S.A., El-Wakil E.S., Potential therapeutic and prophylactic effects of Asafoetida in murine cryptosporidiosis, J Parasit Dis, 44, pp. 646-653, (2020)
[6]  
Abubakar I., Aliyu S., Arumugam C., Et al., Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis, Br J Clin Pharmacol, 63, pp. 387-393, (2007)
[7]  
Abubakar I., Aliyu S.H., Arumugam C., Et al., Prevention and treatment of cryptosporidiosis in immunocompromised patients, Cochrane Database Syst Rev, (2007)
[8]  
Al-Awar A., Kupai K., Veszelka M., Et al., Experimental diabetes mellitus in different animal models, J Diabetes Res, (2016)
[9]  
Amadi B., Mwiya M., Musuku J., Et al., Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial, Lancet (london, England), 360, pp. 1375-1380, (2002)
[10]  
Amadi B., Mwiya M., Sianongo S., Et al., High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial, BMC Infect Dis, (2009)